A. Heidland et al., Franz Volhard and Theodor Fahr: achievements and controversies in their research in renal disease and hypertension, J HUM HYPER, 15(1), 2001, pp. 5-16
The clinician, Franz Volhard, and the pathologist, Theodor Fahr, worked clo
sely together in Mannheim from 1909 until 1915 and introduced a novel class
ification of renal diseases. In the monograph entitled 'Die Bright'sche Nie
renkrankheit, Klinik, Pathologie und Atlas' (1914) they differentiated betw
een degenerative (nephroses), inflammatory (nephritides) and arteriosclerot
ic (scleroses) diseases. Nephrosclerosis was divided into the benign and ma
lignant form, of which the latter stood the test of time as a new disease e
ntity. Fahr further divided benign nephrosclerosis into the compensated and
decompensated form - depending on the presence or absence of glomerular in
jury. In the pathogenesis of malignant nephrosclerosis, Volhard stressed th
e decisive role of severe blood pressure elevation, while Fahr postulated a
n inflammatory mechanism, a concept later confirmed by Adalbert Bohle for a
t least a minority of patients. A very far reaching concept of Franz Volhar
d was his idea that pale (renal) hypertension results from a presser substa
nce released from ischaemic kidney(s) contributing - via a vicious circle -
to a further rise in blood pressure with subsequent renovascular injury an
d aggravation of hypertension. This hypothesis was supported in 1930 by ini
tial experiments of his collaborator, Hartwich (demonstrating in dogs a mil
d rise in blood pressure after ligation of branches of the renal artery) an
d definitively proven by Goldblatt (1934) in dogs by induction of severe an
d persistent hypertension after clamping of both renal arteries. The conseq
uent detection of the renin angiotensin system was the final confirmation o
f Volhard's postulated renal presser substance. In the pathogenesis of red
(essential) hypertension, Volhard stressed the role of hereditary factors,
age, obesity and potentially of severe alcoholism. He emphasised a prematur
e reduction of vascular distensibility (due to elastosis of the prearteriol
es), a high cardiac output as well as a dampening of baroceptor function. A
dditionally, Volhard made crucial advances in cardiology and pneumology.